Abstract
There is a widespread belief that psychiatric patients make unreliable informants, especially when it comes to rating the presence and severity of their psychiatric symptoms. Hence it is felt that symptom-rating scales completed by patients are likely to be less accurate and therefore less sensitive to treatment effects than comparable scales completed by psychiatrists or psychologists [1]. (Henceforth, psychiatrist or psychologist-rated scales will be referred to as doctor-rated scales.)
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Arfwidsson, L., d’Elia, G., Laurell, B., Ottossen, O., Perns, C., and Persson, G. 1974. Can self-rating replace doctor’s rating in evaluating antidepressive treatment. Acta Psychiatr. Scand. 50: 16–22.
Blumenthal, M.D. 1975. Measuring depressive symptomatology in a general population. Arch. Gen. Psychiatry 37: 971–978.
Burdock, E.I., Elliott, H.E., Hardesty, A.S., O’Neill, F.J., and Sklar, J. 1960. Biometric evaluation of an intensive treatment programme in a state mental hospital. J. Nerv. Ment. Dis. 130: 271–277.
Burdock, E.I., Hardesty, A.S., Hakerem, G., and Zubin, J. A. 1960. A ward behaviour rating scale for mental patients. J. Clin. Psychol. 16: 246–247.
Caffey, E.M., Jr., Diamond, L.S., Frank, T.V., Grasberger, J.C., Herman, L., Klett, C.J., and Rothstein, C. 1964. Discontinuation or reduction of chemotherapy in chronic schizophrenics. J. Chronic Dis. 17: 347–358.
Carroll, B.J., Fielding, J.M., and Blashki, T.J. 1973. Depression rating scales: A critical review. Arch. Gen. Psychiatry 28: 361–366.
Dehnel, L.L., Vestre, N.D., and Schiele, B.C. 1968. A controlled comparison of clopenthizal and perphenazine in a chronic schizophrenic population. Current Therapeutics Research 10: 169–176.
Fisher, S. 1976. Measurement of anxiety in outpatient trials: Detection of bias in patient and doctor ratings. Psychopharmaeol. Bull. 12: 17–18.
Friedhoff, A. J., and Alpert, M. 1960. The effect of chlorpromazine on the variability of motor task performance in schizophrenics. J. Nerv. Ment. Dis. 130: 110–116
Gernor, R. H., Catlin, O. H., Gorelick, D. A., Hui, K. K., and Li, C. H. 1980. B-Endorphin. Arch. Gen. Psychiatry 37: 642–645.
Goldberg, H.L., Finnerty, R.J., LaBrie, R., and Rickels, K. 1978. A study of concordance between observer and patient rating scales. Psychopharmacol. Bull. 14: 7–10.
Goldberg, S.C., Klerman, G.L., and Cole, J.O. 1965. Changes in schizophrenic psychopathology and ward behaviour as a function of phenothiazine treatment. Br. J. Psychiatry 111: 120–133.
Hall, W.B., Vestre, N.D., Schiele, B.C., and Zimmerman, R. 1968. A controlled comparison of haloperidol and fluphenazine in chronic treatment-resistant schizophrenics. Diseases of the Nervous System 29: 405–408.
Hanlon, T.E., Nussbaum, K., Wittig, B., Hanlon, D.D., and Kurland, A. A. 1964. The comparative effectiveness of amitriptyline, perphenazine and their combination in the treatment of chronic psychotic female patients. Journal of New Drugs 4: 52–60.
Hamilton, M. 1960. A rating scale for depression. J. Neurol. Neurosurg. Psychiatry 23: 56–62.
Honigfeld, G. 1974. History and current status of its use in pharmacopsychiatric research. Mod. Probl. Pharmacopsychiatry 7: 238–263.
Honigfeld, G., and Klett, C.J. 1965. The nurses’ observation scale for inpatient evaluation: a new scale for measuring improvement in chronic schizophrenia. J. Clin. Psychol. 21: 65–71.
Honigfeld, G., Gillis, R. D., and Klett, C.J. 1966. NOSIE-30: A treatment sensitive ward behaviour scale. Psychol. Rep. 19: 180–182.
Kellner, R. 1971. Part 1. Improvement criteria in drug trials with neurotic patients. Psychol. Med. 1: 416–425.
Kellner, R. 1972. Part 2. Improvement criteria in drug trials with neurotic patients. Psychol. Med. 2: 73–80.
Kellner, R., Simpson, G. M. and Sheffield, B. F. 1977. The value of self-rating scales in drug trials. Psychopharmacol. Bull. 13: 42–43.
Kellner, R., Sheffield, B. F., and Simpson, G. M. 1977. Comparative value of self-rating scales in drug trials. Psychopharmacol. Bull. 13: 12–13.
Kellner, R., Rada, R.T., Anderson, R., and Pathak, D. 1979. The effects of chlordiazepoxide on self-rated depression, anxiety and well-being. Psychopharmacology 64: 185–191.
Kollar, E. J., Pasnav, R.O., Rubin, R.T., Naitch, P., Slater, G.G., and Kales, A. 1979. Psychological, psychophysiological, and biochemical correlates of prolonged sleep deprivation. Am. J. Psychiatry 126: 488–497.
Konik, D.S., Paolino, A.F., Friedman, I., and Hinko, E.M. 1967. Beer and geriatrics, an objective study. Washington Brewers Institute. Unpublished manuscript.
Lasky, J. J., Klett, C.J., Caffey, E.M., Bennett, J.L., Rosenblum, M.P., and Hollister, L.E. 1962. Drug treatment of schizophrenic patients. Diseases of the Nervous System 23: 698–706.
Lorr, M., and Vestre, N. D. 1968. Psychotic Inpatient Profile Manual. Western Psychological Services, Los Angeles.
McNair, D.M. 1974. Self-evaluation of antidepressants. Psychopharmacologia 37: 281–302.
Overall, J.E., and Gorham, D.R. 1960. The brief psychiatric rating scale. Psychol. Rep. 10: 799–812.
Prusoff, B.A., Klerman, G.L., and Paykel, E.S. 1972. Concordance between clinical assessments and patients’ self-report in depression. Arch. Gen. Psychiatry 26: 546–552.
Raskin, A., and Crook, T. H. 1976. Sensitivity of rating scales completed by psychiatrists, nurses and patients to antidepressant drug effects. J. Psychiatr. Res. 13: 31–41.
Raskin, A., and McKeon, J.J. 1971. Super factors of psychopathology in hospitalized depressed patients. J. Psychiatr. Res. 9: 11–19.
Raskin, A., Schulterbrandt, J., Reatig, N., and Rice, C. E. 1967. Factors of psychopathology in interview, ward behaviour and self-report ratings of hospitalized depressives. J. Consult. Psychol. 31: 270–278.
Raskin, A., Schulterbrandt, J., Reatig, N., and McKoon, J.J. 1969. Replication of factors of psychopathology in interview, ward behaviour and self-report ratings of hospitalized depressives. J. Nerv. Ment. Dis. 1: 87–98.
Raskin, A., Schulterbrandt, J.G., Reatig, N., and McKeon, J.J. 1970. Difference response to chlorpromazine, imipramine and placebo. Arch. Gen. Psychiatry 23: 164–173.
Raskin, A., Gershon, S., Crook, T.H., Sathananthan, G., and Ferris, S. 1978. The effects of hyperbaric and normobaric oxygen on cognitive impairment in the elderly. Arch. Gen. Psychiatry 35: 50–56.
Snaith, P. 1981. Rating scales. Br. J. Psychiatry 138: 512–514.
Spielberger, C.D., Gorsuch, R.L., and Lushene, R. 1968. Self-evaluation questionnaire. Consulting Psychologists Press, Palo Alto.
Stoffelmayr, B. E. 1973. The relationship between nurses’ ratings of patient behaviour and observed patient behaviour. Soc. Psychiatry 8: 37–40.
Uhlenhuth, E.H., Glass, R.M., Haberman, S.J., and Kellner, R. 1982. Relative sensitivity of clinical measures in trials of antianxiety agents. In: E. I. Burdock, A. Sudilousky, and S. Gershon (eds.), The Behaviour of Psychiatric Patients — Quantitative Techniques for Evaluation, pp. 393–410. Marcel Dekker, New York.
Vestre, N.D. 1966. Validity data on the Psychotic Reaction Profile. J. Consult. Psychol. 30: 84–85.
Wolpert, A., Sheppard, C., and Merlis, J. 1967. Method for evaluation of behavioural changes in aged hospital patients during anabolic steroid therapy. J. Am. Geriatr. Soc. 15: 470–473.
Zung, W. W.K. 1965. A self-rating depression scale. Arch. Gen. Psychiatry 12: 63–70.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1986 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Raskin, A. (1986). Sensitivity to Treatment Effects of Evaluation Instruments Completed by Psychiatrists, Psychologists, Nurses, and Patients. In: Sartorius, N., Ban, T.A. (eds) Assessment of Depression. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-70486-4_31
Download citation
DOI: https://doi.org/10.1007/978-3-642-70486-4_31
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-70488-8
Online ISBN: 978-3-642-70486-4
eBook Packages: Springer Book Archive